Alpha 2.0
Login Register
» Articles » PMID: 14099134

EXPERIENCE WITH ALKYLATING AGENTS IN THE TREATMENT OF CHILDREN WITH THE NEPHROTIC SYNDROME

Overview
Journal Med J Aust
Specialty General Medicine
Date 1963 Dec 14
PMID 14099134
Citations 14
Authors
J H COLDBECK
Affiliations
Soon will be listed here.
Citing Articles

Management of the nephrotic syndrome due to primary renal disease.

Can Med Assoc J. 1967; 96(1):52-3.

PMID: 6016589 PMC: 1936880.

Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

White R, Cameron J, Trounce J Br Med J. 1966; 2(5518):853-60.

PMID: 5917404 PMC: 1944072. DOI: 10.1136/bmj.2.5518.853.

Cyclophosphamide therapy in the nephrotic syndrome in childhood.

Moncrieff M, White R, Oggs C, Cameron J Br Med J. 1969; 1(5645):666-71.

PMID: 5774315 PMC: 1982698. DOI: 10.1136/bmj.1.5645.666.

Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.

DRUMMOND K, Hillman D, MARCHESSAULT J, Feldman W Can Med Assoc J. 1968; 98(11):524-31.

PMID: 5643296 PMC: 1923912.

Cyclophosphamide therapy of idiopathic nephrosis.

Grushkin C, Fine R, Heuser E, Lieberman E Calif Med. 1970; 113(6):1-5.

PMID: 5486515 PMC: 1501850.